Aarey Drugs & Pharmaceuticals Ltd. (AAREYDRUGS): Aarey Drugs & Pharmaceuticals Share Price Near 52-Week High as Stock Trades at Rs 98.36
- September 16, 2026
- Posted by: Harsh Piplani
- Category: News
Aarey Drugs Share Price is Rs 98.36, down 0.85% today, and is trading close to its 52-week high with a market capitalisation of Rs 306.27 crore as of 16 September 2026 at 3:25 PM IST. The move keeps Aarey Drugs & Pharmaceuticals Ltd. (AAREYDRUGS) in focus on Univest because the stock remains near its yearly high while the latest numbers also allow a clear look at valuation, sector context and recent price behaviour. The latest Univest figures confirm the price event, but they do not establish a company-specific catalyst. For readers tracking Aarey Drugs Share Price Today, the key question is not just where the stock is trading, but how the current quote compares with its one-year high, the day’s range and the company’s valuation profile in the Trading industry.
Aarey Drugs Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 98.36 |
| Previous Close | Rs 99.2 |
| Today's Move | Rs -0.84 (-0.85%) |
| Open | Rs 97.84 |
| High | Rs 99.97 |
| Low | Rs 94.25 |
| Turnover | Rs 0.06 crore |
| Market Capitalisation | Rs 306.27 crore |
Aarey Drugs & Pharmaceuticals Ltd. (AAREYDRUGS) traded at Rs 98.36 versus the previous close of Rs 99.2, a fall of 0.85%. The stock opened at Rs 97.84, reached a high of Rs 99.97 and touched a low of Rs 94.25.
Aarey Drugs Share Price was at Rs 98.36 versus the previous close of Rs 99.20, marking a fall of Rs 0.84 or 0.85%. The stock opened at Rs 97.84 and moved between Rs 94.25 and Rs 99.97 during the trading day, placing it near the upper end of the day’s range. Turnover stood at Rs 0.06 crore, which gives a factual read on traded value without implying anything about participation or demand. From a 52-week perspective, the current price is close to the yearly high zone and keeps Aarey Drugs Share Price Today on screens that track 52 Week High Stocks and Stocks in News. Univest data shows a price event that is relevant because the share remains close to its one-year high while trading activity in value terms stays visible.
For readers searching Aarey Drugs Stock News or Aarey Drugs Share Price Update, the important point is straightforward: the stock is trading near its 52-week peak, but the latest figures alone do not provide a company-specific explanation for the move.
Aarey Drugs & Pharmaceuticals Ltd. (AAREYDRUGS) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 306.27 crore |
| P/E Ratio | 73.34x |
| P/B Ratio | 2.04x |
| ROE | 3.02% |
| ROCE | 6.38% |
| EPS | Rs 1.35 |
| Book Value Per Share | Rs 48.62 |
| Dividend Yield | 0% |
Aarey Drugs & Pharmaceuticals Ltd. (AAREYDRUGS) fundamental metrics show P/E 73.34x, P/B 2.04x, ROE 3.02%, ROCE 6.38%. These figures provide context only and are not a buy or sell signal.
Aarey Drugs & Pharmaceuticals Ltd. has a market capitalisation of Rs 306.27 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 73.34x, P/B at 2.04x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 3.02% and ROCE of 6.38%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 1.35, book value per share of Rs 48.62, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 13.48x, median ROE of 4.09%, median ROCE of 6.05%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Trading |
| Industry | Trading |
| Benchmark Scope | same industry |
| Company P/E Ratio | 73.34x |
| Benchmark Median P/E | 13.48x |
| Benchmark Average P/E | 83.6x |
| Benchmark P/E Range | 0x to 8,715.25x |
| Company P/B Ratio | 2.04x |
| Benchmark Median P/B | 1.38x |
| Company ROE | 3.02% |
| Benchmark Median ROE | 4.09% |
| Company ROCE | 6.38% |
| Benchmark Median ROCE | 6.05% |
| Company Market Capitalisation | Rs 306.27 crore |
| Benchmark Median Market Cap | Rs 52.98 crore |
Aarey Drugs & Pharmaceuticals Ltd. (AAREYDRUGS) is classified under sector: Trading and industry: Trading.
Aarey Drugs & Pharmaceuticals Ltd. (AAREYDRUGS) has a P/E ratio of 73.34x, which is above the benchmark median of 13.48x, a difference of +444.07%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Aarey Drugs & Pharmaceuticals Ltd. (AAREYDRUGS) has a ROE of 3.02%, which is below the benchmark median of 4.09%, a difference of -26.16%. Aarey Drugs & Pharmaceuticals Ltd. (AAREYDRUGS) has a ROCE of 6.38%, which is above the benchmark median of 6.05%, a difference of +5.45%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Evexia Lifecare Ltd. | EVEXIA | 309.76 | 202.23 | 0.6 | 0.15 | 0.16 |
| Polo Queen Industrial & Fintech Ltd. | PQIF | 298.48 | 113.27 | 1.5 | 1.59 | 2.98 |
| Silkflex Polymers (India) Ltd. | SILKFLEX | 314.67 | 25.89 | 6.62 | 29.23 | 22.77 |
| PH Trading Ltd. | VEGA | 315.21 | 10.45 | 2.3 | 7.53 | 2.59 |
| Omnitex Industries (India) Ltd. | OMNITE | 317.12 | 0 | 1.75 | 0.82 | 1.38 |
Aarey Drugs & Pharmaceuticals Ltd. (AAREYDRUGS) has a P/E ratio of 73.34x compared with the displayed peer median of 25.89x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 3.02% compares with a peer median of 1.59% across the companies shown in the table. ROCE stood at 6.38% versus the displayed peer median of 2.59%, providing a capital-efficiency comparison. Aarey Drugs & Pharmaceuticals Ltd. (AAREYDRUGS) has a market capitalisation of Rs 306.27 crore. Among the 5 peers shown, 4 have a larger market capitalisation.
Why Investors Are Watching Aarey Drugs
- Aarey Drugs Share Price is Rs 98.36 and remains near its 52-week high.
- The stock moved -0.85% from the previous close of Rs 99.20.
- Market capitalisation stands at Rs 306.27 crore.
- P/E is 73.34, compared with the Trading industry median of 13.48.
- ROCE is 6.38%, slightly above the sector median of 6.05%.
About Aarey Drugs
Aarey Drugs & Pharmaceuticals Ltd. operates in the Trading sector and Trading industry. Univest classifies it within the same industry comparison set used for valuation and ratio benchmarking. For readers tracking Aarey Drugs Company News or Aarey Drugs Financial Results, the key public identifiers in this article are the company name, symbol AAREYDRUGS, market capitalisation, earnings multiple and return ratios. That makes Aarey Drugs Share Price easier to place within the broader Trading universe on Univest.
Frequently Asked Questions
What is Aarey Drugs Share Price today?
Ans. Aarey Drugs Share Price is Rs 98.36. It is trading near the 52-week high and is below the previous close of Rs 99.20 by Rs 0.84. The stock moved -0.85% so far today.
Why is Aarey Drugs Share Price in focus today?
Ans. The stock is in focus because it is trading close to its 52-week high. The latest Univest figures show a near-high price event, while turnover and valuation add context.
How much did Aarey Drugs share move today?
Ans. Aarey Drugs Share Price moved -0.85% today, or Rs 0.84 lower than the previous close. It opened at Rs 97.84 and traded between Rs 94.25 and Rs 99.97.
What is the market capitalisation of Aarey Drugs?
Ans. Aarey Drugs has a market capitalisation of Rs 306.27 crore. That places it in the same industry benchmark set used by Univest for Trading sector comparisons and peer analysis.
Is Aarey Drugs Share Price expensive on earnings?
Ans. The stock’s P/E ratio is 73.34, which is above the Trading industry median of 13.48. That makes it materially higher than the benchmark median, though below the benchmark average of 83.60.
What do Aarey Drugs EPS and book value show?
Ans. EPS is Rs 1.35 and book value is Rs 48.62 per share. EPS shows earnings attributable to each share, while book value shows the accounting net worth behind each share.
How does Aarey Drugs compare with sector benchmarks?
Ans. Aarey Drugs Share Price sits alongside a sector P/E median of 13.48 and a P/B median of 1.38. Its ROCE of 6.38% is slightly above the sector median of 6.05%.
What should investors monitor in Aarey Drugs Share Price next?
Ans. Investors can monitor whether Aarey Drugs remains near its 52-week high, how valuation compares with the Trading industry, and whether upcoming company financial figures alter the current ratio profile.
Track Aarey Drugs Share Price on Univest
Use Aarey Drugs & Pharmaceuticals Ltd. (AAREYDRUGS) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
You can track Aarey Drugs Share Price Live on Univest for price updates, market cap, valuation ratios, EPS, book value, dividend yield, and the latest 52-week levels. Univest also brings together Aarey Drugs Stock News, Aarey Drugs Latest News, Aarey Drugs Fundamental Analysis and Aarey Drugs Stock Analysis in one place for easier monitoring.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
